// App-Quantinova.ai

: LIVER SURVEILLANCE IN PATIENTS WHO RECEIVED INOTUZUMAB OZOGAMICIN (IO) FOR RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA

Researchers

Presenter

  • Giovanni Marconi

Principal Investigators

  • Giovanni Martinelli

  • Elton Dajti

  • Maria Chiara Abbenante

  • Chiara Sartor

  • Luigina Vanessa Alemanni

  • Jacopo Nanni

  • Sarah Parisi

  • Giovanni Marasco

  • Gianluca Cristiano

  • Amanda Vestito

  • Francesca Bonifazi

  • Stefania Paolini

  • Antonio Curti

  • Davide Festi

  • Michele Cavo

  • Cristina Papayannidis

  • Antonio Colecchia

Medical Centers

  • "Seragnoli" Institute of Hematology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy

  • Gastroenterology and Endoscopy Unit, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy

  • Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy

  • Institute of Hematology,Azienda Ospedaliero-Universitaria S.Orsola-Malpighi,Bologna,Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

  • Folate Hydrolase 1

Drug/Treatment

  • Inotuzumab ozogamicin

  • Ursodeoxycholic acid

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved